MAP4K4 regulates integrin-FERM binding to control endothelial cell motility-Reference-Cited by-同舟云学术

MAP4K4 regulates integrin-FERM binding to control endothelial cell motility

Published:2015-03 Issue:7544 Volume:519 Page:425-430
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Vitorino Philip,Yeung Stacey,Crow Ailey,Bakke Jesse,Smyczek Tanya,West Kristina,McNamara Erin,Eastham-Anderson Jeffrey,Gould Stephen,Harris Seth F.,Ndubaku Chudi,Ye Weilan

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature14323.pdf

Reference44 articles.

1. Ridley, A. et al. Cell migration: integrating signals from front to back. Science 302, 1704–1709 (2003)

2. Hynes, R. O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673–687 (2002)

3. Calderwood, D. A., Campbell, I. D. & Critchley, D. R. Talins and kindlins: partners in integrin-mediated adhesion. Nature Rev. Mol. Cell Biol. 14, 503–517 10.1038/nrm3624. (2013)

4. Gardel, M. L., Schneider, I. C., Aratyn-Schaus, Y. & Waterman, C. M. Mechanical integration of actin and adhesion dynamics in cell migration. Annu. Rev. Cell Dev. Biol. 26, 315–333 (2010)

5. Dan, I., Watanabe, N. M. & Kusumi, A. The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol. 11, 220–230 (2001)

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating integrins with the hallmarks of cancer;Matrix Biology;2024-06

2. MAP4K4 exacerbates cardiac microvascular injury in diabetes by facilitating S-nitrosylation modification of Drp1;Cardiovascular Diabetology;2024-05-09

3. Syndromic craniosynostosis caused by a novel missense variant in MAP4K4: Expanding the genotype–phenotype relationship in RASopathies;Clinical Genetics;2024-04-28

4. Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress;Expert Opinion on Therapeutic Targets;2024-04-02

5. Considerations on the implementation of MAP4K4 inhibitors as cancer treatment;Expert Opinion on Therapeutic Targets;2024-03-03